{"id":"NCT01968967","sponsor":"Pfizer","briefTitle":"Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events","officialTitle":"A Phase 3 Double-blind, Randomized, Placebo-controlled, Parallel-group Study To Assess The Efficacy, Long-term Safety And Tolerability Of Pf-04950615 In Subjects With Primary Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-10-29","primaryCompletion":"2016-07-05","completion":"2017-07-10","firstPosted":"2013-10-24","resultsPosted":"2017-07-24","lastUpdate":"2018-07-31"},"enrollment":2139,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Hyperlipidemia"],"interventions":[{"type":"DRUG","name":"Bococizumab (PF-04950615; RN316)","otherNames":[]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Bococizumab (PF-04950615; RN316)","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study is a multicenter, randomized study in subjects with high cholesterol receiving highly effective statins to assess the efficacy, safety and tolerability of Bococizumab (PF-04950615;RN316) to lower LDL-C.","primaryOutcome":{"measure":"Percent Change From Baseline in Fasting Low Density Lipoprotein Cholesterol (LDL-C) at Week 12","timeFrame":"Baseline, Week 12","effectByArm":[{"arm":"Placebo (Treatment Period)","deltaMin":1,"sd":22.55},{"arm":"Bococizumab 150 mg (Treatment Period)","deltaMin":-54.9,"sd":26.84}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":249,"countries":["United States","Canada","Colombia","France","Hungary","Lithuania","Mexico","Romania","Russia","Spain","Taiwan","United Kingdom"]},"refs":{"pmids":["37994400","37658997","35277540","29685591","28304227"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B1481020&StudyName=Randomized%20Clinical%20Trial%20of%20RN316%20%28PF-04950615%29%20in%20Subjects%20with%20Hyperlipidemia%20or%20Mixed%20Dyslipidemia%20at%20Risk%20of%20Cardiovascular%20Events"]},"adverseEventsSummary":{"seriousAny":{"events":150,"n":1065},"commonTop":["Injection site reaction","Upper respiratory tract infection","Hypertension"]}}